Literature DB >> 18775755

Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings.

R C A Schellekens1, F Stellaard, D Mitrovic, F E Stuurman, J G W Kosterink, H W Frijlink.   

Abstract

Conventional pH-responsive coatings used for oral drug delivery to the lower parts of the gastro-intestinal tract often show a poor performance. A new system for site-specific pulsatile delivery in the ileo-colonic regions is described. The system is based on the non-percolating incorporation of disintegrants in a coating which consists further of a continuous matrix of pH-responsive polymer (Eudragit S). Extensive in vitro release studies were performed in which coatings with different concentrations and disintegrants were studied and compared to non-disintegrant containing coatings. In vitro data show that the incorporation of swelling agents in an Eudragit S-coating still allows delayed release in the simulated terminal ileum. The pulse time and the robustness could be improved compared to conventional Eudragit S-coatings. The augmented pH-responsiveness of the new coating was related to the swelling index of the applied disintegrant. Based on the in vitro data comparing different swelling agents, Ac-di-sol appears to be the best performing swelling agent. A proof-of-concept study in human subjects was performed to investigate the performance of the new system in vivo. Coated capsules containing the stable isotope (13)C(6)-glucose as the test compound were administered and the occurrence of (13)CO(2) in the breath of the subjects was measured. It could be shown that the coating is able to resist the environmental conditions in the stomach and duodenum and delay release until deeper parts of the intestines are reached. Furthermore, the capsule is able to maintain a pulsatile release profile. It is concluded that the structured incorporation of swelling agents in pH-responsive polymers improves the delayed, pulsatile release kinetics of coated capsules. In a proof-of-concept in vivo study it was shown that the newly developed coating enables pulsatile delivery of the content to the lower parts of the intestines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775755     DOI: 10.1016/j.jconrel.2008.08.008

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  12 in total

1.  A non-invasive, low-cost study design to determine the release profile of colon drug delivery systems: a feasibility study.

Authors:  Marina J M Maurer; Reinout C A Schellekens; Klaus D Wutzke; Gerard Dijkstra; Herman J Woerdenbag; Henderik W Frijlink; Jos G W Kosterink; Frans Stellaard
Journal:  Pharm Res       Date:  2012-03-16       Impact factor: 4.200

2.  Characterization of soy polysaccharide and its in vitro and in vivo evaluation for application in colon drug delivery.

Authors:  B M Ursekar; P S Soni; Abhijit A Date; M S Nagarsenker
Journal:  AAPS PharmSciTech       Date:  2012-06-28       Impact factor: 3.246

Review 3.  Applications of stable isotopes in clinical pharmacology.

Authors:  Reinout C A Schellekens; Frans Stellaard; Herman J Woerdenbag; Henderik W Frijlink; Jos G W Kosterink
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

4.  Delivery of human immunodeficiency virus vaccine vectors to the intestine induces enhanced mucosal cellular immunity.

Authors:  Lingshu Wang; Cheng Cheng; Sung-Youl Ko; Wing-Pui Kong; Masaru Kanekiyo; David Einfeld; Richard M Schwartz; C Richter King; Jason G D Gall; Gary J Nabel
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

5.  Proof-of-concept study on the suitability of 13C-urea as a marker substance for assessment of in vivo behaviour of oral colon-targeted dosage forms.

Authors:  R C A Schellekens; G G Olsder; S M C H Langenberg; T Boer; H J Woerdenbag; H W Frijlink; J G W Kosterink; F Stellaard
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

6.  A novel multilayered multidisk oral tablet for chronotherapeutic drug delivery.

Authors:  Zaheeda Khan; Yahya E Choonara; Pradeep Kumar; Lisa C du Toit; Valence M K Ndesendo; Viness Pillay
Journal:  Biomed Res Int       Date:  2013-08-20       Impact factor: 3.411

7.  A Three-Pulse Release Tablet for Amoxicillin: Preparation, Pharmacokinetic Study and Physiologically Based Pharmacokinetic Modeling.

Authors:  Jin Li; Hongyu Chai; Yang Li; Xuyu Chai; Yan Zhao; Yunfan Zhao; Tao Tao; Xiaoqiang Xiang
Journal:  PLoS One       Date:  2016-08-01       Impact factor: 3.240

8.  Ileo-Colon Targeting of the Poorly Water-Soluble Drug Celecoxib Using a pH-Dependent Coating in Combination with Self-Emulsifying Drug Delivery or Solid Dispersion Systems.

Authors:  Annemarie Broesder; Julia M E Berends; Sophie M Scheepers; Duong N Nguyen; Henderik W Frijlink; Wouter L J Hinrichs
Journal:  Pharmaceutics       Date:  2021-05-15       Impact factor: 6.321

9.  Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection.

Authors:  Qing Zhu; James Talton; Guofeng Zhang; Tshaka Cunningham; Zijian Wang; Robert C Waters; James Kirk; Bärbel Eppler; Dennis M Klinman; Yongjun Sui; Susan Gagnon; Igor M Belyakov; Russell J Mumper; Jay A Berzofsky
Journal:  Nat Med       Date:  2012-07-15       Impact factor: 53.440

10.  Effects of colon-targeted vitamins on the composition and metabolic activity of the human gut microbiome- a pilot study.

Authors:  Van T Pham; Sophie Fehlbaum; Nicole Seifert; Nathalie Richard; Maaike J Bruins; Wilbert Sybesma; Ateequr Rehman; Robert E Steinert
Journal:  Gut Microbes       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.